INO vs NSC · $88.0M cap vs P/E 18, rev $6.46B
Inovio Pharmaceuticals Inc (INO) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
INO currently screens at market cap $88.0M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the INO and NSC stock pages for the full models.
Not investment advice.